Period,symbol,NAV,sharesOutstanding,researchDevelopment,effectOfAccountingCharges,incomeBeforeTax,minorityInterest,netIncome,sellingGeneralAdministrative,grossProfit,ebit,operatingIncome,otherOperatingExpenses,interestExpense,extraordinaryItems,nonRecurring,otherItems,incomeTaxExpense,totalRevenue,totalOperatingExpenses,costOfRevenue,totalOtherIncomeExpenseNet,discontinuedOperations,netIncomeFromContinuingOps,netIncomeApplicableToCommonShares,capitalSurplus,totalLiab,totalStockholderEquity,otherCurrentLiab,totalAssets,commonStock,retainedEarnings,otherLiab,treasuryStock,cash,totalCurrentLiabilities,otherStockholderEquity,propertyPlantEquipment,totalCurrentAssets,shortTermInvestments,accountsPayable,inventory,changeToLiabilities,totalCashflowsFromInvestingActivities,netBorrowings,totalCashFromFinancingActivities,changeToOperatingActivities,issuanceOfStock,changeInCash,totalCashFromOperatingActivities,depreciation,changeToNetincome,capitalExpenditures,WC,language,region,quoteType,quoteSourceName,triggerable,marketState,currency,regularMarketPreviousClose,fullExchangeName,financialCurrency,regularMarketOpen,averageDailyVolume3Month,averageDailyVolume10Day,exchange,longName,messageBoardId,exchangeTimezoneName,exchangeTimezoneShortName,gmtOffSetMilliseconds,market,esgPopulated,regularMarketChange,regularMarketChangePercent,regularMarketTime,regularMarketPrice,regularMarketDayHigh,regularMarketDayRange,regularMarketDayLow,regularMarketVolume,fiftyTwoWeekLowChange,fiftyTwoWeekLowChangePercent,fiftyTwoWeekRange,fiftyTwoWeekHighChange,fiftyTwoWeekHighChangePercent,fiftyTwoWeekLow,fiftyTwoWeekHigh,epsTrailingTwelveMonths,shortName,bookValue,fiftyDayAverage,fiftyDayAverageChange,fiftyDayAverageChangePercent,twoHundredDayAverage,twoHundredDayAverageChange,twoHundredDayAverageChangePercent,marketCap,priceToBook,sourceInterval,exchangeDataDelayedBy,tradeable,firstTradeDateMilliseconds,priceHint,displayName,Beta (5Y Monthly),52-Week Change 3,S&P500 52-Week Change 3,52 Week High 3,52 Week Low 3,50-Day Moving Average 3,200-Day Moving Average 3,Avg Vol (3 month) 3,Avg Vol (10 day) 3,Shares Outstanding 5,Implied Shares Outstanding 6,Float,% Held by Insiders 1,% Held by Institutions 1,Shares Short 4,Short Ratio 4,Short % of Float 4,Short % of Shares Outstanding 4,Shares Short (prior month ) 4,Forward Annual Dividend Rate 4,Forward Annual Dividend Yield 4,Trailing Annual Dividend Rate 3,Trailing Annual Dividend Yield 3,5 Year Average Dividend Yield 4,Payout Ratio 4,Dividend Date 3,Ex-Dividend Date 4,Last Split Factor 2,Last Split Date 3,Fiscal Year Ends,Most Recent Quarter (mrq),Profit Margin,Operating Margin (ttm),Return on Assets (ttm),Return on Equity (ttm),Revenue (ttm),Revenue Per Share (ttm),Quarterly Revenue Growth (yoy),Gross Profit (ttm),EBITDA,Net Income Avi to Common (ttm),Diluted EPS (ttm),Quarterly Earnings Growth (yoy),Total Cash (mrq),Total Cash Per Share (mrq),Total Debt (mrq),Total Debt/Equity (mrq),Current Ratio (mrq),Book Value Per Share (mrq),Operating Cash Flow (ttm),Levered Free Cash Flow (ttm),index,zip,sector,fullTimeEmployees,longBusinessSummary,city,phone,state,compensationAsOfEpochDate,country,website,maxAge,address1,industry,address2
t0,GLPH,-2991839.0,118023000,,,-2130563,-87448,-2112802,471180,0,-481990,-481990,,-57631,,,,0,0,481990,0,-1648573,,-2130563,-2112802,4692859.0,3464391.0,-2991839.0,2797798.0,385604.0,107673.0,-7767420.0,-1.0,-24951.0,37252.0,3464392.0,-24951.0,292552.0,93052.0,28800.0,101404.0,,28784,-264222,184209,221209,60000,37000,-142041,-99028,10810,1914180,-264222,-3371340.0,en-US,US,EQUITY,Delayed Quote,False,PREPRE,USD,0.0009,Other OTC,USD,0.0009,17392,10246,PNK,"Gala Pharmaceutical, Inc.",finmb_128351726,America/New_York,EDT,-14400000,us_market,False,0.0,0.0,1630437561,0.0009,0.0009,9.0E-4 - 9.0E-4,0.0009,76971,0.00088999997,89.0,1.0E-5 - 0.04,-0.0391,-0.97749996,1e-05,0.04,-0.043,GALA PHARMACEUTICAL INC,-0.028,0.0038277777,-0.0029277778,-0.76487666,0.007383846,-0.0064838463,-0.8781123,826160,-0.032142855,15,0,False,1408455000000,4,Gala Pharmaceutical,25.04,-55.00%,30.90%,0.0400,0.0000,0.0038,0.0074,17.39k,10.25k,118.02M,,106.31M,9.99%,0.00%,,,,,,,,,,,0.00%,,,,,"Nov 29, 2018","May 30, 2019",0.00%,0.00%,-287.69%,,,0.00,,-782,-1.48M,-3.57M,-0.0430,,66.05k,0,504.03k,,0.03,-0.03,-595.03k,2.03M,Value,92612,Healthcare,2,"Gala Pharmaceutical, Inc. focuses on the research, development, and commercialization of products derived from the hemp and cannabis plant. The company also provides genetic fingerprinting and sequencing services for various crop species. In addition, it offers consulting services on testing and manufacturing lab designs and SOPs, as well as services to customers for building turnkey labs, drug formulations, and troubleshooting. The company was formerly known as Gala Global Inc. and changed its name to Gala Pharmaceutical, Inc. in January 2018. Gala Pharmaceutical, Inc. was founded in 2010 and is based in Irvine, California.",Irvine,775-321-8238,CA,1546214400,United States,http://www.galapharmaceuticals.com,86400,18881 Von Karman Avenue,Biotechnology,Suite 1440
t-1,GLPH,-1281271.0,118023000,,,-599386,-69687,-577172,227940,0,-230663,-230663,,-27007,,,,0,0,230663,0,-368723,,-599386,-577172,4352635.0,1633091.0,-1281271.0,1029104.0,282633.0,95198.0,-5654618.0,,-74486.0,179293.0,1633091.0,-74486.0,39140.0,243493.0,37200.0,139407.0,,13643,-6703,177500,177500,42190,37000,63095,-107702,2723,410914,-6703,-1389598.0,en-US,US,EQUITY,Delayed Quote,False,PREPRE,USD,0.0009,Other OTC,USD,0.0009,17392,10246,PNK,"Gala Pharmaceutical, Inc.",finmb_128351726,America/New_York,EDT,-14400000,us_market,False,0.0,0.0,1630437561,0.0009,0.0009,9.0E-4 - 9.0E-4,0.0009,76971,0.00088999997,89.0,1.0E-5 - 0.04,-0.0391,-0.97749996,1e-05,0.04,-0.043,GALA PHARMACEUTICAL INC,-0.028,0.0038277777,-0.0029277778,-0.76487666,0.007383846,-0.0064838463,-0.8781123,826160,-0.032142855,15,0,False,1408455000000,4,Gala Pharmaceutical,25.04,-55.00%,30.90%,0.0400,0.0000,0.0038,0.0074,17.39k,10.25k,118.02M,,106.31M,9.99%,0.00%,,,,,,,,,,,0.00%,,,,,"Nov 29, 2018","May 30, 2019",0.00%,0.00%,-287.69%,,,0.00,,-782,-1.48M,-3.57M,-0.0430,,66.05k,0,504.03k,,0.03,-0.03,-595.03k,2.03M,Value,92612,Healthcare,2,"Gala Pharmaceutical, Inc. focuses on the research, development, and commercialization of products derived from the hemp and cannabis plant. The company also provides genetic fingerprinting and sequencing services for various crop species. In addition, it offers consulting services on testing and manufacturing lab designs and SOPs, as well as services to customers for building turnkey labs, drug formulations, and troubleshooting. The company was formerly known as Gala Global Inc. and changed its name to Gala Pharmaceutical, Inc. in January 2018. Gala Pharmaceutical, Inc. was founded in 2010 and is based in Irvine, California.",Irvine,775-321-8238,CA,1546214400,United States,http://www.galapharmaceuticals.com,86400,18881 Von Karman Avenue,Biotechnology,Suite 1440
t-2,GLPH,-811733.0,118023000,,,-208047,-47473,-170195,472244,-2241,-477208,-477208,,-18031,,,,0,0,477208,2241,269161,,-208047,-170195,4290722.0,1120864.0,-811733.0,498524.0,262158.0,92012.0,-5077446.0,,-117021.0,116198.0,1120864.0,-117021.0,35160.0,226998.0,41800.0,83282.0,,-22631,-6703,115321,390321,90906,275000,101582,-288739,2723,-192019,-6703,-893866.0,en-US,US,EQUITY,Delayed Quote,False,PREPRE,USD,0.0009,Other OTC,USD,0.0009,17392,10246,PNK,"Gala Pharmaceutical, Inc.",finmb_128351726,America/New_York,EDT,-14400000,us_market,False,0.0,0.0,1630437561,0.0009,0.0009,9.0E-4 - 9.0E-4,0.0009,76971,0.00088999997,89.0,1.0E-5 - 0.04,-0.0391,-0.97749996,1e-05,0.04,-0.043,GALA PHARMACEUTICAL INC,-0.028,0.0038277777,-0.0029277778,-0.76487666,0.007383846,-0.0064838463,-0.8781123,826160,-0.032142855,15,0,False,1408455000000,4,Gala Pharmaceutical,25.04,-55.00%,30.90%,0.0400,0.0000,0.0038,0.0074,17.39k,10.25k,118.02M,,106.31M,9.99%,0.00%,,,,,,,,,,,0.00%,,,,,"Nov 29, 2018","May 30, 2019",0.00%,0.00%,-287.69%,,,0.00,,-782,-1.48M,-3.57M,-0.0430,,66.05k,0,504.03k,,0.03,-0.03,-595.03k,2.03M,Value,92612,Healthcare,2,"Gala Pharmaceutical, Inc. focuses on the research, development, and commercialization of products derived from the hemp and cannabis plant. The company also provides genetic fingerprinting and sequencing services for various crop species. In addition, it offers consulting services on testing and manufacturing lab designs and SOPs, as well as services to customers for building turnkey labs, drug formulations, and troubleshooting. The company was formerly known as Gala Global Inc. and changed its name to Gala Pharmaceutical, Inc. in January 2018. Gala Pharmaceutical, Inc. was founded in 2010 and is based in Irvine, California.",Irvine,775-321-8238,CA,1546214400,United States,http://www.galapharmaceuticals.com,86400,18881 Von Karman Avenue,Biotechnology,Suite 1440
t-3,GLPH,-1198553.0,118023000,,,-716907,-9621,-711696,306083,0,-308806,-308806,,-22421,,,,0,0,308806,0,-408101,,-716907,-711696,3637493.0,1455330.0,-1198553.0,838156.0,247656.0,58705.0,-4907251.0,,12500.0,14616.0,1455330.0,12500.0,37883.0,209773.0,67800.0,124033.0,2241.0,75619,-6703,30000,75000,58423,45000,-24559,-99559,2723,474750,-6703,-1245557.0,en-US,US,EQUITY,Delayed Quote,False,PREPRE,USD,0.0009,Other OTC,USD,0.0009,17392,10246,PNK,"Gala Pharmaceutical, Inc.",finmb_128351726,America/New_York,EDT,-14400000,us_market,False,0.0,0.0,1630437561,0.0009,0.0009,9.0E-4 - 9.0E-4,0.0009,76971,0.00088999997,89.0,1.0E-5 - 0.04,-0.0391,-0.97749996,1e-05,0.04,-0.043,GALA PHARMACEUTICAL INC,-0.028,0.0038277777,-0.0029277778,-0.76487666,0.007383846,-0.0064838463,-0.8781123,826160,-0.032142855,15,0,False,1408455000000,4,Gala Pharmaceutical,25.04,-55.00%,30.90%,0.0400,0.0000,0.0038,0.0074,17.39k,10.25k,118.02M,,106.31M,9.99%,0.00%,,,,,,,,,,,0.00%,,,,,"Nov 29, 2018","May 30, 2019",0.00%,0.00%,-287.69%,,,0.00,,-782,-1.48M,-3.57M,-0.0430,,66.05k,0,504.03k,,0.03,-0.03,-595.03k,2.03M,Value,92612,Healthcare,2,"Gala Pharmaceutical, Inc. focuses on the research, development, and commercialization of products derived from the hemp and cannabis plant. The company also provides genetic fingerprinting and sequencing services for various crop species. In addition, it offers consulting services on testing and manufacturing lab designs and SOPs, as well as services to customers for building turnkey labs, drug formulations, and troubleshooting. The company was formerly known as Gala Global Inc. and changed its name to Gala Pharmaceutical, Inc. in January 2018. Gala Pharmaceutical, Inc. was founded in 2010 and is based in Irvine, California.",Irvine,775-321-8238,CA,1546214400,United States,http://www.galapharmaceuticals.com,86400,18881 Von Karman Avenue,Biotechnology,Suite 1440
